These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. Reddy VY; Exner DV; Cantillon DJ; Doshi R; Bunch TJ; Tomassoni GF; Friedman PA; Estes NA; Ip J; Niazi I; Plunkitt K; Banker R; Porterfield J; Ip JE; Dukkipati SR; N Engl J Med; 2015 Sep; 373(12):1125-35. PubMed ID: 26321198 [TBL] [Abstract][Full Text] [Related]
23. Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region. Valiton V; Graf D; Pruvot E; Carroz P; Fromer M; Bisch L; Tran VN; Cook S; Scharf C; Burri H Europace; 2019 Feb; 21(2):275-280. PubMed ID: 30202950 [TBL] [Abstract][Full Text] [Related]
24. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI. Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491 [TBL] [Abstract][Full Text] [Related]
25. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Nazarian S; Hansford R; Roguin A; Goldsher D; Zviman MM; Lardo AC; Caffo BS; Frick KD; Kraut MA; Kamel IR; Calkins H; Berger RD; Bluemke DA; Halperin HR Ann Intern Med; 2011 Oct; 155(7):415-24. PubMed ID: 21969340 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of safety and feasibility of leadless pacemaker implantation following the removal of an infected pacemaker. Zhang J; He L; Xing Q; Zhou X; Li Y; Zhang L; Lu Y; Tuerhong Z; Yang X; Tang B Pacing Clin Electrophysiol; 2021 Oct; 44(10):1711-1716. PubMed ID: 34455604 [TBL] [Abstract][Full Text] [Related]
27. Feasibility and long-term effectiveness of a non-apical Micra pacemaker implantation in a referral centre for lead extraction. Bongiorni MG; Della Tommasina V; Barletta V; Di Cori A; Rogani S; Viani S; Segreti L; Paperini L; Soldati E; De Lucia R; Zucchelli G Europace; 2019 Jan; 21(1):114-120. PubMed ID: 29893837 [TBL] [Abstract][Full Text] [Related]
28. The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker. Ritter P; Duray GZ; Zhang S; Narasimhan C; Soejima K; Omar R; Laager V; Stromberg K; Williams E; Reynolds D; Europace; 2015 May; 17(5):807-13. PubMed ID: 25855677 [TBL] [Abstract][Full Text] [Related]
29. Leadless pacing with Micra TPS: A comparison between right ventricular outflow tract, mid-septal, and apical implant sites. Garweg C; Vandenberk B; Foulon S; Haemers P; Ector J; Willems R J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2002-2011. PubMed ID: 31338871 [TBL] [Abstract][Full Text] [Related]
31. Permanent leadless cardiac pacing: results of the LEADLESS trial. Reddy VY; Knops RE; Sperzel J; Miller MA; Petru J; Simon J; Sediva L; de Groot JR; Tjong FV; Jacobson P; Ostrosff A; Dukkipati SR; Koruth JS; Wilde AA; Kautzner J; Neuzil P Circulation; 2014 Apr; 129(14):1466-71. PubMed ID: 24664277 [TBL] [Abstract][Full Text] [Related]
32. Successful replacement of the longest worldwide in situ Nanostim leadless cardiac pacemaker for a Micra Transcatheter Pacing System. Beurskens NEG; Tjong FVY; Quast ABE; Knops RE J Interv Card Electrophysiol; 2018 Mar; 51(2):161-162. PubMed ID: 29335839 [No Abstract] [Full Text] [Related]
33. Safety and feasibility of a midseptal implantation technique of a leadless pacemaker. Hai JJ; Fang J; Tam CC; Wong CK; Un KC; Siu CW; Lau CP; Tse HF Heart Rhythm; 2019 Jun; 16(6):896-902. PubMed ID: 30550834 [TBL] [Abstract][Full Text] [Related]
34. Implantation of the Micra transcatheter pacing system: A single center North India experience. Kumar V; Agarwal R; Singh Yadav M; Dhir S; Kumar V Indian Pacing Electrophysiol J; 2021; 21(1):19-24. PubMed ID: 33217535 [TBL] [Abstract][Full Text] [Related]
35. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. Knops RE; Tjong FV; Neuzil P; Sperzel J; Miller MA; Petru J; Simon J; Sediva L; de Groot JR; Dukkipati SR; Koruth JS; Wilde AA; Kautzner J; Reddy VY J Am Coll Cardiol; 2015 Apr; 65(15):1497-504. PubMed ID: 25881930 [TBL] [Abstract][Full Text] [Related]
36. Preliminary findings on the safety of 1.5 and 3 Tesla magnetic resonance imaging in cardiac pacemaker patients. van Dijk VF; Delnoy PPHM; Smit JJJ; Ramdat Misier RA; Elvan A; van Es HW; Rensing BJWM; Raciti G; Boersma LVA J Cardiovasc Electrophysiol; 2017 Jul; 28(7):806-810. PubMed ID: 28429537 [TBL] [Abstract][Full Text] [Related]
37. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. Garg A; Koneru JN; Fagan DH; Stromberg K; Padala SK; El-Chami MF; Roberts PR; Piccini JP; Cheng A; Ellenbogen KA Heart Rhythm; 2020 Dec; 17(12):2056-2063. PubMed ID: 32763431 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience. Dar T; Akella K; Murtaza G; Sharma S; Afzal MR; Gopinathannair R; Augostini R; Hummel J; Lakkireddy D J Interv Card Electrophysiol; 2020 Jan; 57(1):133-140. PubMed ID: 31907831 [TBL] [Abstract][Full Text] [Related]